Financials
Financial year 2025
PHARMEINSA from Sankt Vith, company number BE0787352463, closed financial year 2025 with a result of € 146,188 after tax. For that financial year PHARMEINSA recorded a gross margin of € 247,327 and equity of € 5,042. Compared with financial year 2024, the result moved from € 184,325 to € 146,188. The company is profitable. The buffer shrank hard: equity is 99 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on March 17, 2026.
€ 5,042
▼ 99% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 146,188
▼ 21% vs 2024
Profit after tax over the fiscal year.
€ 527,185
▲ 39% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 612,000 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
1
Average over the fiscal year, from the social balance sheet.
€ 30,760
▼ 31% vs 2024
€ 30,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 52,241
▼ 26% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 71,269
▼ 21% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 162,210
▲ 132% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 164,799 | € 293,738 | € 312,562 | € 247,327 | ▼ 21% |
| Profit after taxes | € 105,388 | € 176,139 | € 184,325 | € 146,188 | ▼ 21% |
| Equity | € 110,388 | € 286,528 | € 470,853 | € 5,042 | ▼ 99% |
| Total debts | € 142,222 | € 198,677 | € 160,243 | € 752,132 | ▲ € 591,889 |
| Cash | € 122,453 | € 136,731 | € 380,267 | € 527,185 | ▲ 39% |
| Retained profit | € 105,388 | € 281,528 | € 465,853 | € 42 | ▼ € 465,812 |
| Dividend | € 0 | € 0 | € 0 | € 612,000 | |
| Bank debt | € 0 | € 46,537 | € 0 | € 0 | |
| Balance sheet total | € 252,610 | € 485,205 | € 631,096 | € 757,173 | ▲ 20% |
| Employees (FTE) | - | - | 1 | 1 |
Key figures of PHARMEINSA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMEINSA?
What happened at PHARMEINSA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 146,188 (▼ 21% vs 2024). Source: NBB ↗
- New establishment in Sankt Vith. KBO
- Safia Meinköhn became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 105,388 profit in 2022 to € 146,188 profit in 2025.
Paid € 180,732 in corporate taxes since 2022.
Best year ever: 2024, with € 184,325 profit.
On average € 247,300 of value added per employee in 2025.
A new publication or filing at PHARMEINSA? We notify you, reason included.
Follow PHARMEINSADatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Directors
According to the 2025 annual accounts
Safia Meinköhn
Director
since 2022
Establishments
Establishment units
Physical locations of this company
Aachener Strasse 3
4780 Sankt Vith
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0787.352.463
- VAT number
- BE 0787.352.463
- Registered office
- Aachener Strasse 3, 4780 Sankt Vith
- Names & denominations
- PHARMEINSA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 16 June 2022
- Peppol
- Active · Active since 20 Dec 2025
- Contact
- [email protected]
- Activities · NACE
Detailhandel in farmaceutische producten
Detailhandel in cosmetica en toiletartikelen